Stock ACXP ACURX PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Acurx Pharmaceuticals, Inc.

Equities

ACXP

US00510M1045

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
2.23 USD -0.89% Intraday chart for Acurx Pharmaceuticals, Inc. +6.70% -41.78%
May. 15 Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection CI
May. 15 Transcript : Acurx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 15, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ACURX PHARMACEUTICALS, INC. Stock Acurx Pharmaceuticals, Inc.
 35.29M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 54.04B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 41.92B
LONZA GROUP AG Stock Lonza Group AG
 41.96B
CELLTRION, INC. Stock Celltrion, Inc.
 28.35B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.35B
  1. Stock Market
  2. Equities
  3. ACXP Stock
  4. Charts Acurx Pharmaceuticals, Inc.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW